Un-FASN-ing cancer's seat belt: Linking lipid metabolism and antigen presentation

Area of Science:

• Immunology
• Oncology
• Metabolic pathways

Background:

• MHC-II expression on cancer cells correlates with better treatment outcomes.
• Understanding mechanisms that regulate MHC-II is crucial for improving cancer therapies.

Purpose of the Study:

• To identify small molecules that upregulate MHC-II on cancer cells.
• To investigate the role of fatty acid synthase (FASN) in regulating MHC-II expression and tumor growth.

Main Methods:

• Screening of small molecules for MHC-II upregulation on cancer cells.
• Assessing the effect of identified molecules on FASN activity.
• Evaluating the impact of FASN suppression on tumor growth in preclinical models.

Main Results:

• A panel of small molecules was identified that selectively upregulate MHC-II on cancer cells.
• These molecules suppress fatty acid synthase (FASN) activity.
• FASN suppression led to inhibition of tumor growth.

Conclusions:

• Targeting FASN represents a novel strategy to enhance MHC-II expression on cancer cells.
• This approach links lipid metabolism regulation to improved antigen presentation and tumor control.
• Further investigation may reveal potential for combination therapies with immunotherapy.